Class Action Alert: Levi & Korsinsky Reminds Alto Neuroscience, Inc. (ANRO) Investors of September 19, 2025 Deadline

NEW YORK, NY / ACCESS Newswire / August 13, 2025 / If you suffered a loss on your Alto Neuroscience, Inc. (NYSE:ANRO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/alto-neuroscience-inc-lawsuit-submission-form?prid=161196&wire=1&utm_campaign=17 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or […]

MAX ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of MediaAlpha, Inc. Shareholders Who Lost Money

NEW YORK, NY / ACCESS Newswire / August 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of MediaAlpha, Inc. ("MediaAlpha") (NYSE:MAX) concerning possible violations of federal securities laws. On November 4, 2024, MediaAlpha disclosed receipt of a letter from the FTC, which stated that the FTC was "prepared to

CIBC Asset Management Inc. announces termination of the CIBC 2025 Investment Grade Bond Funds

CIBC (TSX: CM) (NYSE: CM) — CIBC Asset Management Inc. (CAM) today announced that it will terminate the CIBC 2025 Investment Grade Bond Fund and the CIBC 2025 U.S. Investment Grade Bond Fund (the “Funds”) on November 28, 2025 (the “Termination Date”), in accordance with the Funds' investment objectives. Effective immediately, except in limited circumstances,

Teva Pharmaceutical Industries Limited Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights – TEVA

NEW YORK, NY / ACCESS Newswire / August 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Teva Pharmaceutical Industries Limited ("Teva Pharmaceutical Industries Limited") (NYSE:TEVA) concerning possible violations of federal securities laws. On July 31, 2025, Teva published a press release reporting the Company’s second quarter 2025 financial

Investors in Replimune Group, Inc. (REPL): Protect Your Rights – Contact Levi & Korsinsky Before September 22, 2025

NEW YORK, NY / ACCESS Newswire / August 13, 2025 / If you suffered a loss on your Replimune Group, Inc. (NASDAQ:REPL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/replimune-group-inc-lawsuit-submission-form?prid=161203&wire=1&utm_campaign=11 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Snowflake Trader Launches Mindset-First Trading Framework to Help Traders Build Consistency and Long-Term Success

FREMONT, CA / ACCESS Newswire / August 13, 2025 / Snowflake Trader has unveiled a new approach to trading education that focuses on the often-overlooked foundation of market success: mindset and process discipline. By combining a structured Trading Playbook with guided exercises, custom-built tools, and a gradual risk-scaling methodology, the platform aims to help beginner

SideChannel Reports Third Quarter Results

Financial results conference call on Wednesday, August 13 @ 4:30 P.M. ET WORCESTER, MA / ACCESS Newswire / August 13, 2025 / SideChannel, Inc. (OTCQB:SDCH) ("SideChannel"), a leading provider of cybersecurity services and technology to emerging and middle market companies, today announced its financial results for the third quarter of the fiscal year ended September

NOVO NORDISK A/S (NYSE: NVO) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Novo Nordisk A/S Investors of Upcoming Deadline

NEW YORK, NY / ACCESS Newswire / August 13, 2025 / Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Novo Nordisk A/S ("Novo" or the "Company") (NYSE: NVO) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit? Do

SAREPTA THERAPEUTICS, INC. (NASDAQ: SRPT) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Sarepta Therapeutics, Inc. Investors of Upcoming Deadline

NEW YORK, NY / ACCESS Newswire / August 13, 2025 / Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Sarepta Therapeutics, Inc. ("Sarepta" or the "Company") (NASDAQ: SRPT) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit? Do

Base Carbon Reports Second-Quarter 2025 Operating and Financial Results

(Neo:BCBN.NE),(Neo:BCBN),(OTC US:BCBNF),(Other OTC:BCBNF), TORONTO, Aug. 13, 2025 (GLOBE NEWSWIRE) — Base Carbon Inc. (Cboe CA: BCBN) (OTCQX: BCBNF) with operations through its wholly-owned subsidiary, Base Carbon Capital Partners Corp. (“BCCPC“, together, with affiliates, “Base Carbon“, or the “Company“), is pleased to announce its second-quarter 2025 consolidated financial results and operational highlights. The Company will host

Scroll to Top